# Mark Emberton

Source: https://onco.cc/people/mark-emberton/  
OnCo record `mark-emberton` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Urologist behind PROMIS and PRECISION, which put MRI before biopsy in the prostate cancer pathway.

## Summary

Mark Emberton was senior investigator of PROMIS and PRECISION, the trials showing that multiparametric MRI before biopsy detects more clinically significant prostate cancers and fewer insignificant ones than standard systematic biopsy, which rewrote diagnostic guidelines worldwide. He pioneered focal therapy with HIFU and cryotherapy and leads interventional oncology research at UCL.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: prostate; imaging; focal-therapy
- Role: Professor of Interventional Oncology and Dean of the Faculty of Medical Sciences, University College London
- Specialisms: Prostate cancer diagnostics; MRI-guided biopsy; Focal therapy; Interventional oncology

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Mark_Emberton
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Emberton%20M%5BAuthor%5D%20prostate%20MRI

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- technologies: [Focused ultrasound & histotripsy](https://onco.cc/technologies/hifu-histotripsy/), [MRI](https://onco.cc/technologies/mri/)
- institutions: [University College London Hospitals / UCL Cancer Institute](https://onco.cc/institutions/uclh/)
- trials: [PRECISION](https://onco.cc/trials/precision-mri/), [PROMIS](https://onco.cc/trials/promis/)
- key papers: [PROMIS: diagnostic accuracy of multiparametric MRI and TRUS biopsy in prostate cancer](https://onco.cc/key-papers/paper-ahmed-promis-multiparametric-mri-lancet-2017/)
- people: [Caroline Moore](https://onco.cc/people/caroline-moore/), [Rakesh Heer](https://onco.cc/people/rakesh-heer/)

---
JSON: https://onco.cc/api/v1/entities/mark-emberton.json